Gil, Fabio http://orcid.org/0000-0002-4008-6123
Juliao-Baños, Fabian http://orcid.org/0000-0002-8610-9925
Amador, Luisa
Castano, Natalia http://orcid.org/0000-0001-7383-6800
Reyes, Juan Manuel http://orcid.org/0000-0003-0806-7173
Funding for this research was provided by:
Pfizer S.A.S
Article History
Accepted: 18 July 2022
First Online: 9 August 2022
Declarations
:
: Juan M. Reyes, Luisa Amador, and Natalia Castano are paid employees of Pfizer S.A.S. Fabio Gil and Fabian Juliao-Baños have received speakers fees from several pharmaceutical companies.
: This work was funded by Pfizer S.A.S.
: JMR and NC had full access to all of the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis. Study concept, design, analysis, or interpretation of data: FG, FJ-B, LA, NC, JMR. Drafting of the manuscript: JMR, NC. Critical revision of the manuscript for important intellectual content: FG, FJ-B, LA.
: No ethics approval is required for this economic evaluation. As only previously published studies were included and reported in this research, no additional formal ethical assessment was required.
: As only previously published studies were included and reported in this research, no informed consent was required.
: As only previously published studies were included and reported in this research, no informed consent for publication was required.
: The data supporting the findings of this study are available within the article and its electronic supplementary materials.
: Code sharing is not applicable to this article.